Pasqal SPAC Merger: What to Watch as BBCQ Heads to Close
Pasqal, the French neutral-atom quantum-computing company, is going public via a merger with Bleichroeder Acquisition Corp. II (Nasdaq: BBCQ). The deal has already closed, and the stock now trades as PSQL, with the key question being whether the company can convert technical milestones into durable commercial revenue.
Pasqal, the French neutral-atom quantum-computing company, is going public via a merger with Bleichroeder Acquisition Corp. II (Nasdaq: BBCQ). The deal has already closed, and the stock now trades as PSQL, with the key question being whether the company can convert technical milestones into durable commercial revenue.
Pasqal is a French quantum-computing company focused on neutral-atom systems. It describes itself as a global leader in neutral-atom quantum computing and says it is building and deploying quantum computers and related services for industry, science, and governments. Its business is centered on QPU sales and QPU-related services, including R&D services, upgrades, maintenance, and other support work.
The company says it has deployed quantum computers globally and is already delivering real-world capability today. Pasqal’s disclosed footprint includes headquarters in France, more than 275 employees at announcement and about 300 worldwide in later prospectus materials, including more than 70 PhDs. It also said it had over 25 clients, including CMA CGM, OVHcloud, Thales, IBM, Sumitomo, Saudi Aramco, Crédit Agricole CIB, and LG Electronics, and that it is part of the IBM Quantum Network with partnerships involving IBM and NVIDIA.
The industry backdrop is still early and highly competitive. The proxy frames the market as moving from research toward commercially useful quantum systems, with industrialization, cloud access, and hybrid quantum/HPC use cases as the main commercial lanes. At the same time, the filing makes clear that quantum computing may never become broadly commercially viable, and Pasqal faces a crowded field that includes IBM, Google, Microsoft, Amazon, Honeywell, IonQ, PsiQuantum, Rigetti, Quantinuum, Xanadu, Infleqtion, Horizon Quantum, IQM, and QuEra.
The SPAC Deal
This de-SPAC values Pasqal at a $2.0 billion pre-money equity value, with investor materials showing a pro forma equity value of $2.6437 billion, less $649.1 million of cash, for a pro forma enterprise value of $1.9946 billion. That is a rich valuation for a company still in early commercialization mode, so shareholders should focus on whether the market is underwriting future technical progress rather than current revenue scale.
The trust math matters. Bleichroeder had 28,750,000 Class A ordinary shares outstanding before the vote, and the investor deck showed $290.6 million from SPAC trust in the no-redemptions case, inclusive of deferred underwriting fees of up to $12.25 million. But the deck also warned that the cash-to-balance-sheet figure does not reflect potential redemptions, and at closing Pasqal disclosed it received only $27.7 million from trust, implying heavy redemptions. That is the main de-SPAC risk: the headline deal size can look large while the actual cash delivered to the business is much smaller.
The financing stack adds more dilution. The deal included $250.0 million of committed convertible financing through $312.5 million of senior unsecured convertible bonds, initially convertible into 26,041,667 New Pasqal ordinary shares, plus 32,552,083 warrants initially exercisable at $12.00 per share. On top of that, the capital structure includes 9,583,333 sponsor/founder shares, 7,750,000 private placement warrants, 9,583,333 public warrants, and the 32,552,083 investment warrants tied to the convertible financing. The business combination was approved on August 25, 2026 and closed on August 27, 2026. BBCQ was the SPAC’s current ticker before closing; the combined company now trades on Nasdaq as PSQL, with public warrants under PSQLW. The first trading window was late August 2026, immediately after closing.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
Pasqal is using the public markets to fund industrial scale-up, extend runway, and support commercialization of a technically ambitious platform. The company has already booked and awarded business, including grants, and the transaction gives it access to a larger capital base than a standalone private raise would likely provide.
The SPAC route also lets Pasqal present long-range operating projections to investors in a way that a traditional IPO process would not. That matters in a sector where the story is still about future adoption, future hardware performance, and future customer conversion. The sponsor-backed structure also gave Pasqal a faster path to market than a conventional IPO, though the tradeoff is heavier dilution and redemption risk.
Financial Highlights
Pasqal’s near-term financials show a company still in build-out mode. Revenue for the six months ended June 30, 2026 was €4.9 million, up from €4.3 million in the prior-year period, a 14% increase. The company also disclosed €66 million-plus of booked and awarded business including grants as of March 2026, which suggests a growing pipeline but not yet a large recurring revenue base.
Losses remain substantial relative to revenue. Loss before tax for the six months ended June 30, 2026 was €53.2 million, and loss for the period was also €53.2 million. Cash and cash equivalents were €110.8 million as of June 30, 2026, and the prospectus says cash and cash equivalents were approximately €312.9 million as of August 27, 2026 after the transaction and related financing. Forward projections in the deck include 200+ logical qubits by end-2029; that is a projection, not a current operating result.
Risk Factors
The biggest de-SPAC-specific risk is redemption-driven cash leakage. The trust could have delivered roughly $290.6 million in the no-redemptions case, but Pasqal ultimately disclosed only $27.7 million from trust at closing, which shows how quickly the cash picture can change. If redemptions are high, the combined company may have less balance-sheet flexibility than the headline deal suggests.
Dilution is another major overhang. Sponsor founder shares, public warrants, private placement warrants, and the convertible-bond warrants all sit ahead of or alongside future equity value. Beyond the capital structure, Pasqal faces the usual early-stage operating risks: limited commercialization history, technical risk that quantum computing may not become commercially viable, the need for additional capital, competition from better-funded rivals and sovereign-backed programs, dependence on strategic partners and specialized suppliers, government-contract concentration, and foreign private issuer / French-law governance and foreign investment restrictions. There is also deal risk in any de-SPAC, but this transaction has already closed.
Comparable Public Companies
The proxy’s closest public comps are IonQ (IONQ), Rigetti Computing (RGTI), and D-Wave Quantum (QBTS). Those names are the clearest public-market reference points for quantum-computing sentiment, and they tend to trade on a mix of revenue growth, technical milestones, and long-duration commercialization narratives rather than near-term earnings.
Relative to those peers, Pasqal is entering the market with a differentiated neutral-atom approach and a more international customer base, but also with the same challenge the whole group faces: investors are paying for optionality. The comp set has generally been volatile, and the market continues to reward milestone execution more than current profitability. Pasqal’s public-market reception will likely track whether it can keep turning technical progress into signed business and repeatable deployment economics.
Other relevant public names in the broader quantum stack include IBM, Microsoft, and Honeywell, but the most direct trading comps for retail investors are IONQ, RGTI, and QBTS.
Like what you're reading?
Get full access to AI-powered research reports, market analysis, and portfolio tools.
The deal is now closed, so the main question is not whether Pasqal gets public — it already is — but whether the post-close stock can hold up after a redemption-heavy transaction and a large dilution stack. Shareholders should watch the actual cash delivered, the pace of commercial bookings, and whether Pasqal can keep converting its technical milestones into customer revenue at a scale that justifies a roughly $2.0 billion enterprise value.
Why this matters now: de-SPACs often reprice once the trust cash, warrants, and convertibles are fully digested by the market. Pasqal has real technical credibility and a differentiated platform, but the setup still favors investors who are comfortable underwriting a long commercialization runway. The stock now trades as PSQL, and the public warrants trade as PSQLW, so the next catalyst is execution, not the merger vote.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
▌The Full Picture
Want the full picture on PSQL?
Everything we track on PSQL in one place — the TickerSpark Score, price charts, key financials, and our latest coverage.